The World Health Organization has announced the theme for World Patient Safety Day 2024 (September 17) as “Improving diagnosis for patient safety.” World Patient Safety Day is the cornerstone of action to promote global health and safety. It is firmly grounded in the fundamental principle of medicine, “first do no harm.”
To improve diagnostic safety, the main objective for patients and families is to actively engage with health workers and healthcare leaders to improve diagnostic processes.
Here’s what you can do:
Understand and engage in the diagnostic journey.
Ensure you understand the diagnostic process, including the steps that you and your healthcare team will take to determine your diagnosis.
Engage actively with your healthcare team by sharing accurate and comprehensive information about your symptoms and medical history from the start.
Prompt your healthcare team to think comprehensively about alternative diagnoses, such as by asking “What else could it be?”
Ask about the purpose, potential risks, alternatives, and follow-up steps of any recommended diagnostic interventions.
Keep track of your health, symptoms, medical visits, and treatments.
Be informed about the expected progression of your illness, potential danger signs, and how to access care if your condition either does not improve or worsens.
Adhere to prescribed treatment plans and attend follow-up appointments.
Ensure continuity, accuracy, and validity of information.
Ask your healthcare team for information and use reliable medical information sources.
Follow up on the results of your diagnostic tests and proactively ask for the report; no news is not always good news.
Don’t be afraid to seek a second opinion if you have any doubts or uncertainties about the initial diagnosis.
Regularly check your health records to ensure that all information is documented, accurate, and up to date.
Speak up with concerns about your diagnosis and care.
Raise any concerns you may have about your diagnosis or the diagnostic process.
Pharmacy mix-ups occurring between two medications
Several mix-ups between the medications INVEGA (paliperidone), which is used to treat schizophrenia, and INTUNIV (guan FACINE ), used to treat attention deficit hyperactivity disorder (ADHD) have been reported to us.
Consumers who use dietary supplements such as vitamins have no way of knowing if the products they select meet certain quality manufacturing standards. They also have no way of knowing if they are dealing with reputable manufacturers. In response, a drug standards organization called the US Pharmacopeia (USP) established The Dietary Supplement Verification Program (DSVP).